Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Amarin and Lotus Pharmaceuticals Announce Exclusive Partnership to Commercialize VAZKEPA®
Tuesday, August 01, 2023Amarin Corporation and Lotus Pharmaceuticals have entered into significant longterm exclusive partnership to distribute and commercialise VAZKEPA icosapent ethyl in ten countries
Leads Biolabs Receives Approval for First-in-Human Clinical Trials of LBL-034 in Relapsed/Refractory Multiple Myeloma
Monday, July 31, 2023Nanjing Leads Biolabs has received approval from both the National Medical Products Administration NMPA and the US Food and Drug Administration FDA for its Investigational New Drug IND applications for LBL an innovative antiGPRCDCD bispecific antibod...
Transcenta Holding Announces Approval to Initiate Phase II Clinical Trial of TST002 (Blosozumab)
Monday, July 31, 2023Transcenta Holding announced that it has received approval from the China Centre for Drug Evaluation CDE to conduct a Phase II clinical trial of their drug candidate TST also known as Blosozumab Blosozumab is a humanised antisclerostin monoclonal ant...
WuXi Vaccines Achieves GMP Release for First Drug Substance Facility in China
Friday, July 28, 2023WuXi Vaccines announced the successful GMP Good Manufacturing Practise release for its first drug substance DS manufacturing facility in Suzhou China
Ayala Pharmaceuticals and Biosight Enter into Merger Agreement
Friday, July 28, 2023Ayala Pharmaceuticals announced they have entered into a definitive merger agreement forming a new combined company that will operate under the name Ayala Pharmaceuticals
Hummingbird Bioscience Initiates HMBD-001 Phase IB Trials in Australia and Partners with Omico
Thursday, July 27, 2023Hummingbird Bioscience has announced a significant step in advancing clinical development by initiating two Phase IB clinical trials in Australia
LianBio Partner Tarsus Pharmaceuticals Receives FDA Approval for XDEMVY™
Thursday, July 27, 2023LianBios partner Tarsus Pharmaceuticals has received approval from the US Food and Drug Administration FDA for XDEMVY lotilaner ophthalmic solution
HaemaLogiX Enters into Agreement with Peter MacCallum Cancer Centre
Wednesday, July 26, 2023HaemaLogiX and Peter MacCallum Cancer Centre have jointly entered into a codevelopment agreement to conduct the first in human Phase I trial of HaemaLogiXs CART immunotherapy KMACART for kappatype multiple myeloma
Fapon Launches Chemiluminescence Immunoassay Analyser
Wednesday, July 26, 2023Fapon launched its newest chemiluminescence immunoassay system named the Shine i This cuttingedge analyser is designed to be highspeed and fully automated boasting an extraordinary ultrahigh throughput capability of tests per hour
HanchorBio Announces Approval for Multi-Regional Clinical Trial of HCB101
Tuesday, July 25, 2023HanchorBio has received approval from the Taiwan Food and Drug Administration TFDA for its investigational new drug IND application enabling them to proceed with a multiregional clinical trial of their novel drug candidate HCB
